Although significant advances are being made in the fight against the disease, cancer remains a key public concern and a tremendous burden on European societies. Prostate cancer is no different.
With demographic ageing and the shift towards chronic conditions, the differences in national legislation on healthcare issues must be diminished to improve healthcare services and outcomes for less expenditure. New cost-efficient treatments, better quality of life and equal access for all European citizens require more actions at EU level.
The European Prostate Cancer Awareness Day (EPAD) aims to raise awareness, understanding and knowledge of the management of prostate diseases in general and prostate cancer in particular. By joining forces during a yearly event, key policy makers, scientific associations and European patient groups review and discuss how to change the management of prostate cancer across Europe to provide a more holistic and personalised care for patients.